Prof. Dr. Stefan Offermanns

Max-Planck-Institute for Heart and Lung Research
Dept. of Pharmacology

Research topics:

  • Metabolic and cardiovascular diseases

  • Tumor cell metastasis

  • G-protein-coupled receptors

We pursue both basic science projects and projects with the aim to solve medical problems. In basic sciences projects, we aim at understanding how cells of the vascular and metabolic system, the heart as well as tumor cells respond to chemical and mechanical stimuli to maintain homeostasis and to adapt to changing microenvironments. More medically oriented scientific projects deal with the mechanisms of pathophysiological processes and drug actions, in particular in the cardiovascular and metabolic system as well as in cancer with the option to carry the projects to a translational level.

 

Research areas:

1) Metabolic signaling in obesity and diabetes

Metabolic disorders, such as obesity and type-2 diabetes, are risk factors for various diseases including cancer and cardiovascular disorders, and the number of obese and diabetic patients is dramatically increasing worldwide.

In the past, we have identified new regulatory mechanisms of adipocyte turnover and adipocyte function through autocrine regulatory loops (Ahmed et al., 2010) and by inflammatory signaling pathways that regulate adipocyte survival and browning (Sassmann et al., 2016). We have also identified positive and negative modulators of glucose-stimulated insulin secretion (Tang et al., 2015; Tunaru et al., 2018) and have analyzed the mechanism mediating obesogenic adipogenesis (Wang et al., 2020a) and adipocyte survival during obesity (Wang et al., 2020b).

More recent work described a new role of the endothelial insulin receptor in insulin action and its inhibition by endothelial adrenomedullin signalling as a central mechanism of obesity-induced diabetes (Cho et al., 2025).

Future work will focus on the regulation of adipocyte and β-cell turnover and function in healthy and disease states as well as on understanding how metabolic disorders such as obesity promote cancer progression and cardiovascular disorders.

References

Wang L, Wang S, Shi Y, Li R, Günther S, Yuan Z, Liu E, Offermanns S. (2020b) YAP and TAZ protect against white adipocyte cell death during obesity. Nat. Commun. 11:5455

Cho H, Lai CC, Bonnavion R, Alnouri MW, Wang S, Roquid KA, Kawase H, Campos D, Chen M, Weinstein LS, Martínez A, Looso M, Sanda M, Offermanns S. (2025) Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes. Science 387: 674-682.

Wang L, Wang S, Shi Y, Li R, Günther S, Yuan Z, Liu E, Offermanns S (2020b) YAP and TAZ protect against white adipocyte cell death during obesity. Nat Commun. 11: 5455.

Wang S, Cao S, Arhatte M, Li D, Shi Y, Kurz S, Hu J, Wang L, Shao J, Atzberger A, Wang Z, Wang C, Zang W, Fleming I, Wettschureck N, Honoré E, Offermanns S. (2020a) Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice. Nat Commun. 11: 2303.

Tunaru S, Bonnavion R, Brandenburger I, Thomas D, Scholich K, Offermanns S. (2018) 20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1 (GPR40). Nat. Commun. 9: 177

 

 

2) Tumor cell metastasis

Metastasis, the spreading of tumor cells mainly through the vascular system, accounts for the majority of cancer-associated deaths. However, the complex processes underlying tumor cell dissemination and growth of metastasis have remained poorly understood. Increasing evidence indicates that the microenvironment of the metastatic site plays a critical role in determining the progression of metastatic cancer. This includes the pre-metastatic niche which forms under the influence of ill-defined factors released from the primary tumor before tumor cells reach their metastatic sites. After tumor cells have arrived at places of metastasis, a local microenvironment forms and influences the fate of tumor cells which may die, grow or enter into a state of dormancy. Dormancy of metastasized tumor cells requires still poorly-understood conditions which support survival, suppress proliferation and may even provide resistance to therapeutic agents.

 

In the past, we have focused on the interaction of tumor cells with endothelial cells in the context of extravasation at metastatic sites (Strilic et al., 2016; Strilic and Offermanns, 2017), and we recently identified endothelial mechanisms mediating tumor cell dormancy (Roquid et al., 2025). In the future, we plan to further characterize mechanisms underlying tumor cell intravasation, survival and extravasation, and to identify local and systemic mechanisms which regulate tumor cell dormancy.

References

Roquid KA, Vucetic A, Dyukova E, Hanssen MJ, Cho, H, Bonnavion, R, Mattonet K, Looso M, Sanda M, Strilic B, Offermanns S. (2025) Lung endothelial PEAR1 induces tumor cell dormancy. Mol. Cancer 24, 278.

Nakayama A, Roquid KA, Iring A, Strilic B, Günther S, Chen M, Weinstein LS, Offermanns S. (2023) Suppression of CCL2 angiocrine function by adrenomedullin promotes tumor growth. J Exp Med. 220, e20211628

Strilic B, Offermanns S. (2017) Intravascular Survival and Extravasation of Tumor Cells. Cancer Cell 32: 282-293

Strilic B, Yang L, Albarrán-Juárez J, Wachsmuth L, Han K, Müller UC, Pasparakis M, Offermanns S. (2016) Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis. Nature 536: 215-218

 

3) Mechanotransduction in the cardiovascular system and its relevance for vascular tone regulation and atherosclerosis

Fluid shear stress exerted by the flowing blood is crucial for the development of blood vessels but is also one of the major regulators of the vascular tone by inducing nitric oxide (NO) formation in endothelial cells, which relaxes vascular smooth muscle cells. Blood flow is also a key factor in the development of atherosclerosis, which mainly occurs in regions of arteries exposed to disturbances in fluid flow. Some of the endothelial mechanosensing and mechanotransduction mechanisms activated by laminar or disturbed flow to promote atheroprotective or atherogenic signaling have recently been identified. Understanding these fundamental processes provides new insights into the pathophysiology of cardiovascular diseases such as arterial hypertension and atherosclerosis.

We have identified some of the upstream mechanosensing and mechanosignaling mechanisms in endothelial cells, which involve the mechanosensitive cation channel Piezo1 and G-protein-coupled receptors (Wang et al., 2016; Albarrán-Juárez et al., 2018; Iring et al., 2019). Recent work aims at the identification of novel mechanosensitive and mechanotransducing processes in endothelial cells and other vascular cells which are differentially involved in anti-inflammatory (atheroprotective) and pro-inflammatory (atherogenic) signaling induced by laminar and disturbed flow, respectively. This includes the recently identified PKN2-mediated regulation of eNOS by laminar flow (Jin et al., 2021), the laminar flow-induced tenascin-X-mediated inhibition of endothelial-to-mesenchymal transition and atherosclerosis (Liang et al., 2022), the role of PIezo1 in integrating low flow and leukocyte adhesion to promote leukocyte extravasation (Wang et al., 2022) as well as the regulation of histone H3.3 phosphorylation by PKN1 to link disturbed flow-induced signalling to vascular inflammation and atherosclerosis (Jin et al., 2025). The ultimate goal is to better understand how endothelial dysfunction contributes to vascular diseases in order to identify new approaches to prevent cardiovascular disorders at an earlier stage as it is currently possible.

References

Kawase H, Liu S, Kurz S, Bengelsdorff V, Bonnavion R, Jin YJ, Roquid KA, Cho H, Liang G, Banićević M, Shiva N, Yunes-Leites PS, Günther S, Tombor L, Dimmeler S, Looso M, Mattonet K, Wettschureck N, Müller UC, Offermanns S. (2026) Endothelial soluble APP/APLP2 promote heart repair through KIT-mediated angiogenesis. Sci Adv. 12, eaeh0301.

Cho H, Lai CC, Bonnavion R, Alnouri MW, Wang S, Roquid KA, Kawase H, Campos D, Chen M, Weinstein LS, Martínez A, Looso M, Sanda M, Offermanns S. (2025) Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes. Science. 387, 674-682.

Jin YJ, Liang G, Li R, Wang S, Alnouri MW, Bentsen M, Kuenne C, Günther S, Yan Y, Li Y, Wettschureck N, Offermanns S. (2025) Phosphorylation of endothelial histone H3.3 serine 31 by PKN1 links flow-induced signaling to proatherogenic gene expression. Nat .Cardiovasc. Res. 4, 180-196.

Li R, Shao J, Jin YJ, Kawase H, Ong YT, Troidl K, Quan Q, Wang L, Bonnavion R, Wietelmann A, Helmbacher F, Potente M, Graumann J, Wettschureck N, Offermanns S. (2023) Endothelial FAT1 inhibits angiogenesis by controlling YAP/TAZ protein degradation via E3 ligase MIB2. Nat Commun. 14, 1980.

Wang S, Wang B, Shi Y, Möller T, Stegmeyer RI, Strilic B, Li T, Yuan Z, Wang C, Wettschureck N, Vestweber D, Offermanns S. (2022) Mechanosensation by endothelial PIEZO1 is required for leukocyte diapedesis. Blood 140: 171-183

Liang G, Wang S, Shao J, Jin Y, Xu L, Yan Y, Günther S, Wang L, Offermanns S. (2022) Tenascin-X Mediates Flow-Induced Suppression of EndMT and Atherosclerosis. Circ Res. 130: 1647-1659

Jin YJ, Chennupati R, Li R, Liang G, Wang S, Iring A, Graumann J, Wettschureck N, Offermanns S. (2021) Protein kinase N2 mediates flow-induced eNOS activation and vascular tone regulation. J. Clin. Invest. 131:e145734

Iring A, Jin YJ, Albarrán-Juárez J, Siragusa M, Wang S, Dancs PT, Nakayama A, Tonack S, Chen M, Künne C, Sokol AM, Günther S, Martínez A, Fleming I, Wettschureck N, Graumann J, Weinstein LS, Offermanns S (2019) Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure. J. Clin. Invest. 130:2775-2791

Albarrán-Juárez J, Iring A, Wang S, Joseph S, Grimm M, Strilic B, Wettschureck N, Althoff TF, Offermanns S. (2018) Piezo1 and Gq/G11 promote endothelial inflammation depending on flow pattern and integrin activation. J. Exp. Med. 215: 2655-2672

Wang SP, Chennupati R, Iring A, Kaur H, Wettschureck N, Offermanns S. (2016) Endothelial Piezo1 controls blood pressure by mediating flow-induced ATP release. J. Clin. Invest. 126: 4527-4536

 

4) G-protein-coupled receptors

G-protein-coupled receptors (GPCRs) are the largest receptor family in mammals, with about 800 receptors encoded in the human genome. Almost half of the receptors are olfactory receptors, whereas the remaining receptors respond to a wide spectrum of different ligands. For about 150 GPCRs no ligand has so far been described, making them “orphan GPCRs”. Every cell of the body expresses at least 15 to 20 GPCRs, which are involved in the regulation of all body functions. Their high ligand selectivity and their central and specific role in the modulation of physiological and pathophysiological processes make GPCRs ideal drug targets, and about a third of all approved drugs act through GPCRs.

In the past, we have identified new receptors activated by metabolites such as lactate, ketone bodies and free fatty acids, receptors binding chemokines (Le Mercier et al., 2021) or receptors activated by specialized pro resolving lipid mediators (SPMs) (Alnouri et al., 2024). Employing complex mouse genetics, we have been able to elucidate the role of several of these receptors in the regulation of insulin secretion (Tang et al., 2015; Tunaru et al., 2018, Chen et al., 2025), in endothelial flow sensing and blood pressure regulation (Wang et al., 2015; Iring et al., 2019) or in the regulation of vascular insulin sensitivity (Cho et al., 2025). Current work mainly focuses on orphan GPCRs and aims at the identification of new physiological GPCR ligands mainly in the areas of the cardiovascular system, metabolism and cancer

References

Chen X, Shao J, Brandenburger I, Qian W, Hahnefeld L, Bonnavion R, Cho H, Wang S, Hidalgo J, Wettschureck N, Geisslinger G, Gurke R, Wang Z, Offermanns S. (2025) FFAR4-mediated IL-6 release from islet macrophages promotes insulin secretion and is compromised in type-2 diabetes. Nat. Commun. 16, 3422.

Cho H, Lai CC, Bonnavion R, Alnouri MW, Wang S, Roquid KA, Kawase H, Campos D, Chen M, Weinstein LS, Martínez A, Looso M, Sanda M, Offermanns S. (2025) Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes. Science. 387, 674-682.

Alnouri MW, Roquid KA, Bonnavion R, Cho H, Heering J, Kwon J, Jäger Y, Wang S, Günther S, Wettschureck N, Geisslinger G, Gurke R, Müller CE, Proschak E, Offermanns S. (2024) SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor. Proc Natl Acad Sci U S A. 121, e2407130121.

Le Mercier A, Bonnavion R, Yu W, Alnouri MW, Ramas S, Zhang Y, Jäger Y, Roquid KA, Jeong HW, Sivaraj KK, Cho H, Chen X, Strilic B, Sijmonsma T, Ralf Adams R, Schroeder T, Rieger MA, Offermanns S. (2021) GPR182 is an endothelium-specific atypical chemokine receptor that maintains hematopoietic stem cell homeostasis. Proc. Natl. Acad. Sci. USA. 118, e2021596118

Iring A, Jin YJ, Albarrán-Juárez J, Siragusa M, Wang S, Dancs PT, Nakayama A, Tonack S, Chen M, Künne C, Sokol AM, Günther S, Martínez A, Fleming I, Wettschureck N, Graumann J, Weinstein LS, Offermanns S (2019) Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure. J. Clin. Invest. 130: 2775-2791

Tunaru S, Bonnavion R, Brandenburger I, Preussner J, Thomas D, Scholich K, Offermanns S. (2018) 20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1. Nat. Commun. 9: 177

Wang S, Iring A, Strilic B, Albarrán Juárez J, Kaur H, Troidl K, Tonack S, Burbiel JC, Müller CE, Fleming I, Lundberg JO, Wettschureck N, Offermanns S (2015). P2Y2 and Gq/G11 control blood pressure by mediating endothelial mechanotransduction. J. Clin. Invest. 125: 3077-3086

 

Go to Editor View